June 06, 2022
4 min watch
Save
VIDEO: Metabolically healthy obesity is transient
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEW ORLEANS — In this video exclusive, James R. Gavin III, MD, PhD, talks with Jamy D. Ard, MD, about the misleading concept of metabolically healthy obesity, its effect of delaying early treatment and the benefit of small weight losses.
Gavin is clinical professor of medicine at Emory University and chief medical officer of Healing Our Village. He is a Healio | Endocrine Today Co-Editor. Ard is professor of epidemiology and prevention and co-director of the Weight Management Center at the Wake Forest School of Medicine and an Endocrine Today Editorial Board Member.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Ard reports receiving research funding from Boehringer Ingelheim, Epitomee, Nestle Health Sciences and Eli Lilly, and serving as a consultant for Nestle Health Sciences, Eli Lilly and Novo Nordisk. Gavin reports receiving consulting fees from Abbott, Medtronic and Novo Nordisk.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.